IPO · Energy · Proposed listing on Nasdaq
LIS Technologies IPO: how the business makes money
LIS Technologies is developing a laser process to enrich uranium for reactors. It has no revenue and lost $21.5 million in FY2025, the year to Oct 31, 2025.
- Proposed ticker
- LIS
- Exchange
- Nasdaq
- Price range
- $5.00–$7.00 (as of Nov 18, 2026)
- Expected pricing
- Not stated
- Latest filing checked
- S-1/A dated Nov 18, 2026
From the page's filings; page last updated .
By Hardik Bhandare · Checked against filings: . Editorial policy. Corrections
Follow LIS Technologies
Email me when it prices and starts trading.
We'll send a confirmation email first. See our privacy policy.
LIS Technologies Inc. · Oak Ridge, Tennessee · Founded 2021
Based on the amended registration statement (Form S-1/A) dated .
Figures: from the preliminary prospectus (S-1), subject to change.
An amended registration statement gives the expected price range and the number of shares offered.
Last updated
- Revenue, nine months to Jul 31, 2026
- $0
- Net loss, nine months to Jul 31, 2026
- $29.7M
- Technology readiness level, March 2025 assessment
- 4 of 9
- Expected price range, S-1/A of Nov 18, 2026
- $5.00 to $7.00
- Officers and directors before the IPO, Nov 13, 2026 (counting options)
- 31.22%
The short version
The LIS Technologies IPO in 5 points
1 · What it sells
LIS Technologies has nothing on sale: it is developing CRISLA, a laser process to enrich uranium for reactors, which an independent assessment placed at technology readiness level 4 of 9 in March 2025.
2 · Who pays it
No one pays LIS Technologies for a product yet: revenue was $0 in FY2025 and in the nine months to Jul 31, 2026, when private share sales brought most of its $25.3 million of financing.
3 · What it keeps from $100
With no revenue, LIS Technologies keeps nothing from sales: its FY2025 operating loss was $15.8 million and its net loss $21.5 million, which includes a $7.2 million non-cash charge on shares owed for the CRISLA purchase.
4 · Where the operating profit comes from
LIS Technologies has no operating profit: in the nine months to Jul 31, 2026 it spent $15.8 million on general and administrative costs and $11.4 million on research and development, for a net loss of $29.7 million.
5 · The one thing to watch
The S-1/A filed Nov 18, 2026 estimates about $74 million of cash needs for the 12 months to Jul 31, 2027, and shows $18.8 million of cash at Jul 31, 2026 and about $16.4 million of money after costs at the $6.00 midpoint.
Sources: From LIS Technologies' S-1/A filed Nov 18, 2026 · checked
Each week: the next company due to report earnings, explained in 5 points.
No tips. Unsubscribe anytime.
We'll send a confirmation email. See our privacy policy.
01The business in one line
What does LIS Technologies do?
LIS Technologies wants to enrich uranium with lasers and sell it as reactor fuel; no one buys its fuel yet, so money from share sales funds the work.
- It had no revenue from its start on Dec 31, 2021 to Jul 31, 2026, and no agreements to sell fuel, per the S-1/A.
- Its operating loss was $15.8 million in FY2025 (the year to Oct 31, 2025). Its net loss was $21.5 million.
02The offer
What is the LIS Technologies IPO?
- New shares sold by the company
- 3.1 million shares
- To list on
- Nasdaq
- Proposed ticker
- LIS
- Lock-up on existing holders
- 180 days
- New shares: the company sells 3,100,000 shares at an expected $5.00 to $7.00, as stated in the S-1/A filed Nov 18, 2026. The money, after underwriting costs, goes to the company.
- Selling stockholders: none. No existing holder sells in this offering.
- Money after costs is about $16.4 million at the $6.00 midpoint (S-1/A, Nov 18, 2026). Each $1.00 change in the price moves it by about $2.9 million.
- Two underwriters are named: Titan Partners Securities as sole bookrunner and Northland Capital Markets as co-manager. They get a 6.5% discount, a 1.15% expense allowance and up to $200,000 of costs.
- Titan also gets a warrant for 217,000 shares, 7% of those offered. Its exercise price is 115% of the IPO price, and it can be exercised from the seventh month after closing.
- CEO Jay Jiang Yu and President Christo J. Liebenberg each indicated interest in buying up to $250,000 of shares at the IPO price. The S-1/A says this is not binding.
- An affiliate of Titan bought shares in a private sale before this offering, per the S-1/A.
- The company has applied to list on the Nasdaq Capital Market as LIS. The offering will not complete if the listing is not approved.
Executive officers, directors and their affiliates agree not to sell for 180 days after the prospectus date. Other holders of 0.5% or more may sell in stages: 25% after 90 days, a further 25% from 120 days and a further 50% from 180 days, counted from the day before the first Nasdaq trade. The offered shares are freely tradable, except any bought by affiliates.
Share classes and votes
- Underwriters
- 2 named in the S-1 (lead: Titan Partners Securities LLC (sole bookrunner))
- Controlled company
- The S-1/A does not say LIS Technologies will be a controlled company under Nasdaq rules.
Price terms (as of Nov 18, 2026)
Prices are as of Nov 18, 2026, from the offer documents. They are facts about the offer, not a view on the price.
- Expected price range
- $5–$7 per share
- Offering size
- $18.6MCityfort calculation from S-1/A filed Nov 18, 2026: 3,100,000 shares × $6.00 (midpoint of the range) ÷ 1 million. At $5.00 it is $15.50 million; at $7.00, $21.70 million. With the underwriters' option on 465,000 more shares it is $17.83 million, $21.39 million and $24.96 million.
- Market value at this price
- $449MCityfort calculation from S-1/A filed Nov 18, 2026: $6.00 (midpoint of the range) × 74,811,408 shares outstanding after the offering ÷ 1 million. At $5.00 it is $374.06 million; at $7.00, $523.68 million. The S-1/A states no market valueShare price × number of shares: what all the shares were worth at one dated price. Learn more. The share count includes 2,250,000 unvested Starfire Industries shares. It leaves out the underwriters' option, 28,955,007 options and restricted stock units (Cityfort calculation from S-1/A filed Nov 18, 2026), and Titan's warrant for 217,000 shares.
- Lead underwriters
- Titan Partners Securities LLC (sole bookrunner)
- Transfer agent
- VStock Transfer LLC
Learn: How to read an S-1: Anthropic's IPO registration statement · IPO lock-up agreements: what they are and when they end
03Where the new money goes
What will LIS Technologies do with the money it raises?
- Research and development on enrichment products, laser and separator design, LIST Island site work and construction, test work and scoping studiesAbout 67.5% of the money after costs, per the S-1/A. That is about $11.1 million of about $16.4 million at $6.00 (Cityfort calculation from S-1/A filed Nov 18, 2026).Amount not fixed
- Marketing, promotion and business developmentAbout 12.5% of the money after costs, per the S-1/A. That is about $2.1 million at $6.00 (Cityfort calculation from S-1/A filed Nov 18, 2026).Amount not fixed
- Working capital and general corporate purposes, including regulatory work, intellectual property, hiring and contractorsAbout 20% of the money after costs, per the S-1/A. That is about $3.3 million at $6.00 (Cityfort calculation from S-1/A filed Nov 18, 2026).Amount not fixed
The S-1/A says the company may change these amounts and has broad discretion. It also says the road to a commercial plant will be "far more costly than the net proceeds".
Only the shares the company sells raise money for it; money from shares sold by existing stockholders goes to them.
04Key dates
What are the key dates for the LIS Technologies IPO?
Learn: IPO lock-up agreements: what they are and when they end · How to read an S-1: Anthropic's IPO registration statement
Sources (3)
- LIS Technologies Inc. EDGAR filing list (submissions data), read Nov 19, 2026
- LIS Technologies Inc. Amendment No. 2 to Form S-1 (S-1/A), filed Nov 18, 2026 (dated Nov 17, 2026; Registration No. 333-299634)
- LIS Technologies Inc. free writing prospectus (investor presentation) dated Nov 18, 2026, superseding the Nov 6, 2026 FWP
05What it sells
What does LIS Technologies sell?
Low-enriched uranium (planned, not on sale)
Fuel material for commercial reactors, small modular reactors and microreactors. The company says in its S-1/A that selling it needs regulatory approvals and commercial-scale operations.
CRISLA laser process (in development)
A laser process to separate uranium types, first demonstrated in the early 1990s. An independent assessment in March 2025 placed it at technology readiness level 4 of 9, which means validated at laboratory scale.
Other possible uses (early evaluation)
The company says in its S-1/A (Nov 18, 2026) that it is looking at higher-enriched fuel (HALEU, up to 20%), medical and stable isotopes, and fuel work with NANO Nuclear.
Think of it like this
Like concentrating a very weak mixture: enrichment raises the share of the useful uranium type, here from about 0.7% to 3% to 5%.
What it does
- Does: Runs laboratory-scale CRISLA tests at a leased site in Oak Ridge, Tennessee
- Does: Owns a 206-acre site, LIST Island, where it plans a commercial plant
- Does: Does small government study jobs, $255,908 in FY2025, which it reports as other income
What it does not do
- Does not: Sell enriched uranium: the S-1/A says commercial production and sales have not started
- Does not: Have an NRC license for a commercial plant: the S-1/A says it is preparing the application
- Does not: Use a commercially proven method: the S-1/A says laser enrichment has been studied for over 50 years and none is commercial
06Who pays it
Who pays LIS Technologies?
LIS Technologies does not disclose how much each type of customer pays.
No paying fuel customers
Revenue was $0 in FY2024, FY2025 and the nine months to Jul 31, 2026. The S-1/A says there are no offtake or future fuel purchase agreements.
Targeted customers (not yet paying)
Operators of commercial light-water reactors, and developers of small modular reactors and microreactors, per the S-1/A.
NANO Nuclear (related party, no firm terms)
A 15-year agreement gives each side "preferred customer" status: feedstock to LIS Technologies, enriched product to NANO. The S-1/A says definitive commercial terms are not yet agreed.
U.S. government study work (not revenue)
$255,908 from an Air Force Phase I contract and a Department of Energy task order in FY2025. The S-1/A calls it incidental and puts it in other income.
Stock buyers (not customers)
Financing brought in $25.3 million in the nine months to Jul 31, 2026, mostly private share sales, and $26.8 million in FY2025.
How spread out the customers are
With $0 of revenue, there is no customer split to show.
07How the money flows · FY2025
How does money flow through LIS Technologies?
Money in
- Revenue (nothing sold yet)$0M
- Other income (interest and incidental government work)$1.4M
The company
LIS Technologies
$1.4M came in
Money out
- General and administrative$11.9M
- Research and development$3.9M
- Revaluing shares owed for the CRISLA purchase (non-cash)$7.2M
- Net loss−$21.5M
- LIS Technologies sold nothing in FY2025, the year to Oct 31, 2025: revenue was $0.
- Other income was $1.4 million: about $1.2 million of interest and about $0.3 million of incidental government work.
- General and administrative costs were $11.9 million, and research and development $3.9 million. That made an operating loss of $15.8 million. Stock-based pay, which uses no cash, was $5.3 million.
- A non-cash charge of $7.2 million came from revaluing shares still owed for the CRISLA purchase.
- Costs were $21.5 million more than the money that came in. That is the net loss. Cash used in operations was smaller, at $8.3 million.
08What it needs to run
What does LIS Technologies need to run?
Uranium feedstock and special equipment
The tests use uranium hexafluoride (UF6), a uranium gas. A UF6 cylinder arrived in October 2026. The S-1/A says supply of feedstock, fluorine, cylinders and equipment is concentrated. It says the company may have to buy some equipment, such as vacuum pumps, from abroad.
Lasers
It owns the two lasers Cameco used for UF6 experiments in 1993. Starfire Industries is developing a custom laser and holds 3,000,000 of its shares, 2,250,000 of them unvested and tied to milestones.
Sites
A leased 7,000 sq ft office plus access to a lab of about 7,000 sq ft in Oak Ridge, at $7,000 a month. It owns LIST Island (206 acres, about $8 million) and 150 Americus Ave (about 38,000 sq ft, $6,160,000).
Licenses
Tennessee issued a radiological material license for laboratory-scale work in December 2025. The S-1/A says an NRC license is required before building or running a commercial plant.
Money
Management estimates cash needs of about $74 million for the 12 months to Jul 31, 2027. It estimates about $1.38 billion for the planned LEU-3 Facility (S-1/A, Nov 18, 2026).
People
29 full-time employees at Sep 30, 2026, per the S-1/A. Others work as contractors.
09How it makes money
How does LIS Technologies make money?
LIS Technologies has no profit engine yet: share sales pay for research and sites, and nothing is sold.
In the nine months to Jul 31, 2026 it spent $15.8 million on general and administrative costs and $11.4 million on research and development. That was an operating loss of $27.2 million and a net loss of $29.7 million. It also spent $24.9 million on land, a building and construction costs.
Research and development spending, $ million
$1.4$3.9
FY2024 to FY2025
- Raise money by selling shares
- Test CRISLA at laboratory scale
- Scale up equipment and prepare sites
- Obtain an NRC license and build a plant
- Sell enriched uranium; no plant, NRC plant license or sales agreement exists yet
↺ Step 5 feeds back into step 1.
10Competitors and what protects it
Who does LIS Technologies compete with?
Centrus Energy
NYSE: LEU
Runs a gas centrifuge plant in Piketon, Ohio, licensed by the NRC to produce enriched uranium, per the S-1/A.
Urenco
Privately held. Runs a licensed gas centrifuge plant in Eunice, New Mexico, per the S-1/A.
Orano
Privately held. Applied for an NRC license for a gas centrifuge plant in Oak Ridge, Tennessee. The S-1/A says the NRC anticipates finishing its review in April 2027.
Global Laser Enrichment
A private joint venture. Applied for an NRC license for a laser plant in Paducah, Kentucky. The S-1/A says the NRC anticipates finishing its review in January 2027.
General Matter
Privately held, founded in 2024. Filed a letter of intent with the NRC for an enrichment license, per the S-1/A.
What protects the business
Each strength is scored 1 (weak) to 5 (strong) for the business, with the reason. It is not a rating of the share.
- Technology maturity1 of 5
An independent assessment in March 2025 placed CRISLA at level 4 of 9. The S-1/A says laser enrichment has been studied for over 50 years and none is commercial.
- Licenses1 of 5
It holds a Tennessee license for laboratory-scale work, issued December 2025. It does not hold the NRC license a commercial plant needs; Centrus Energy and Urenco do.
- Patents2 of 5
One issued U.S. patent, number 10,319,486, expected to expire Feb 2, 2037, plus five trademark applications and trade secrets.
- Government program access2 of 5
One of six companies in a ten-year Department of Energy program. It was not among the three companies awarded $900 million each in January 2026.
Weak spot
No commercial plant, license or customer
Centrus Energy and Urenco already run licensed U.S. plants. LIS Technologies has $0 of revenue, no fuel purchase agreements and a process at level 4 of 9.
11Where growth could come from
Where could LIS Technologies' growth come from?
LIS Technologies says in its S-1/A (Nov 18, 2026) that it targets a Pilot Plant around 2030 and a larger LEU-3 Facility around 2033. It calls its timing estimates only. SWU, a separative work unit, measures enrichment effort.
Phase 1: laboratory results
EarlyUF6 cylinder delivered in October 2026; the company expects experiments to begin before the end of 2026 (S-1/A, Nov 18, 2026)
The company says in its S-1/A (Nov 18, 2026) that Phase 1 runs from 2025 to 2027. It aims to re-demonstrate and optimize CRISLA results at laboratory scale.
Status: Early, too early to judge.
Phase 3: Pilot Plant
EarlyAbout 50 metric tons of low-enriched uranium and about 0.5 million SWU a year, around 2030 (company estimate; S-1/A, Nov 18, 2026)
This phase covers site work, an NRC license and plant design, per the S-1/A (Nov 18, 2026). The company says the NRC application is in preparation.
Status: Early, too early to judge.
Phase 4: LEU-3 Facility
EarlyIn phases from around 2033: about 3.0 million SWU a year at first, possibly about 5.0 million later. Designed for about 500 metric tons a year, at about $1.38 billion (company estimates; S-1/A, Nov 18, 2026)
The S-1/A (Nov 18, 2026) says this needs financing and regulatory approval, and may not be finished on time, on budget or at all. It says expansion to 5.0 million SWU depends on market conditions, financing, approvals, customer demand and performance. Physical construction had not started at Jul 31, 2026.
Status: Early, too early to judge.
Department of Energy program
EarlyOne of six companies; $3.4 billion anticipated across all six over ten years (S-1/A, Nov 18, 2026)
Work comes only through task orders, and the S-1/A (Nov 18, 2026) says the department need not order beyond a minimum. Its one task order, capped at $515,000, finished in May 2025.
Status: Early, too early to judge.
U.S. demand for enrichment
NewAbout 11 million to 39 million SWU in 2045, against U.S. capacity under 5 million SWU a year (industry data from UxC, as cited in the S-1/A, Nov 18, 2026)
These are industry data from UxC, as cited in the S-1/A (Nov 18, 2026), and depend on low and high-growth scenarios. The S-1/A says the publications it cites were not prepared on its behalf.
Status: New, recently announced.
Status compares progress with what the company itself said it would do: Working = on track against what the company said; Mixed = partly on track; Behind = behind the company's own plan; New = recently announced; Early = too early to judge.
12The numbers · Consolidated · US$
How has LIS Technologies done?
Revenue
$0MFY2025
Revenue was $0 in FY2024, in FY2025 and in the nine months to Jul 31, 2026.
US$
See the numbers
Net income
−$21.5MFY2025
Net loss rose from $13.7 million in FY2024, including $8.8 million of stock-based pay, to $21.5 million in FY2025, including $5.3 million of stock-based pay and a $7.2 million non-cash charge.
US$
See the numbers
Free cash flow
−$10.2MFY2025
Free cash flow (Cityfort calculation from S-1/A filed Nov 18, 2026) was −$10.2 million in FY2025 and −$39.7 million in the nine months to Jul 31, 2026, when $24.9 million went on land, a building and construction costs.
US$ · cash from operations minus spending on plants and equipment
See the numbers
With $0 of revenue, profit per $100 of revenue cannot be calculated for any period.
See all yearly numbers
EBITDA here = operating income plus depreciation and amortization (from the cash flow statement). Fiscal years are the company's own: October 31. Net income is the share belonging to the company's owners.
LIS Technologies says in its S-1/A that it is an emerging growth company, so the filing gives two audited years instead of three.
Latest part-year · Nine months ended Jul 31, 2026 (9 months to Jul 31, 2026)
- Revenue
- $0M
- Net profit
- −$29.7M
- EPS (not annualized)
- −$0.47
A part-year can't be compared with a full year. Audited figures from the S-1/A (interim period unaudited), converted from US$ (whole dollars) to US$ million.
Learn: Fiscal years that don't end in December: Nvidia's FY2027 explained · Stock-based compensation and dilution: pay that becomes shares
13Financial strength · Jul 31, 2026
How much debt does LIS Technologies have?
- Total debt$0M
- Cash and investments$18.8M
- Net cash (cash minus debt)$18.8M
- Net worth (shareholders' money)$32.4M
- Debt to equity
- 0×
- $ of debt for every $1 of shareholders' money
- Net cash of $18.8 million is a Cityfort calculation from S-1/A filed Nov 18, 2026: cash, with no borrowings on the balance sheet.
- Cash was $33.2 million at Oct 31, 2025. Accumulated deficit reached $65.4 million at Jul 31, 2026.
- Liabilities include $12.8 million of consideration payable in equity, for shares still owed under the CRISLA purchase, and $0.5 million of lease liabilities.
- Property and equipment was $29.0 million: LIST Island land $8.0 million, 150 Americus land $0.2 million and building $5.9 million, and construction in progress of $3.8 million at 203 Victorius and $11.0 million for the LEU-3 Facility.
- Management estimates about $74 million of cash needs for the 12 months to Jul 31, 2027: about $18 million for operations, $28 million for CRISLA laboratory work, $4 million for other systems and $24 million for scaled facilities (S-1/A, Nov 18, 2026).
- The S-1/A (Nov 18, 2026) says existing cash funds that plan "only into the first quarter of fiscal 2027", and that these conditions raise substantial doubt about continuing as a going concern. It adds that deferring discretionary spending funds required costs for at least a year, and management concludes this has "alleviated the substantial doubt".
- The S-1/A (Nov 18, 2026) shows cash of $37.8 million and equity of $51.3 million as adjusted for option exercises after Jul 31 and the offering at $6.00.
14Who owns it before the IPO · Nov 13, 2026
Who owns LIS Technologies before the IPO?
- Officers and directors (as a group), shares
- 31.2%
Largest stockholders before the IPO
From the prospectus table of principal stockholders. Holdings fall after the IPO when new shares are sold; the prospectus also shows the holding after the offering.
15Who runs it
Who runs LIS Technologies, and did they deliver?
Jay Jiang Yu
Chief Executive Officer and Chairman · since 2025
CEO since August 2025; Chairman and director since December 2021. He is also President, Secretary, Treasurer and Chairman of NANO Nuclear, and since September 2025 Executive Chairman and President of Human Continuum Inc. FY2025 cash pay: $170,000 consulting, $440,000 salary and $120,000 bonus.
Christo J. Liebenberg
President, Chief Technical Advisor and co-founder · since 2025
President since August 2025; CEO from September 2023 to July 2025. He worked on laser enrichment in South Africa and at Silex, and with ASML's research team on lasers from 2012 to 2024.
Ewurama Rhule
Chief Financial Officer · since 2025
Viktor Chikan
Chief Technology Officer · since 2024
Lloyd Jollay
Chief Operations Officer · since 2026
Atul Sabharwal
Independent director · since 2024
Director since June 2024. Holds 105,000 shares, per the S-1/A.
Jason S. Mencher
Independent director · since 2026
Joined in October 2026.
Eric Forte
Independent director · since 2026
Joined in October 2026. Holds 60,000 shares, per the S-1/A.
16Governance signals
What do LIS Technologies' governance filings show?
- Auditor
- WithumSmith+Brown, PC, since 2025
- Auditor changes
- None in the period covered
- Audit qualifications
- None reported
- Related-party dealings
- LIS Technologies deals with NANO Nuclear, its landlord, a holder and a subcontractor, which shares a founder and officer with it. It also pays consultants tied to NANO and the CEO's brother. The S-1/A says the board "intends to adopt" a related-party policy.
- Credit rating
- Not checked for this page
Flags to know about
related party
CEO's time is split with NANO Nuclear
Mr. Yu is expected to give NANO Nuclear no less than 40 hours a week, and about two hours a week to Human Continuum Inc., a biotechnology company he founded and chairs. His LIS Technologies agreement asks for the time reasonably required, which the S-1/A calls a "lesser contractual standard".
related party
Related-party policy not yet adopted
The S-1/A says the board intends to adopt a policy for its audit committee to review related-party deals.
other
Going-concern doubt, as management describes it
The S-1/A says conditions raise substantial doubt before management's plans. Management concludes that deferring discretionary spending has "alleviated the substantial doubt".
disclosure
The S-1/A differs on whether Phase 2 testing has started
On p.2 the S-1/A says experimental testing of industrial-scale equipment has commenced. On p.87 it says this testing "has not yet commenced".
17Group and related parties
How much does LIS Technologies rely on related parties?
- NANO Nuclear shares a founder, an officer and a significant shareholder with LIS Technologies. CEO Jay Jiang Yu is also NANO's President, Secretary, Treasurer and Chairman.
- NANO Nuclear holds 2,666,667 LIS Technologies shares, 3.72% of the 71,711,408 outstanding at Nov 13, 2026 (Cityfort calculation from S-1/A filed Nov 18, 2026).
- NANO Nuclear is the landlord in Oak Ridge. Rent paid was $63,000 in the nine months to Jul 31, 2026, and $105,000 in FY2025.
- NANO Nuclear is the key subcontractor on the Department of Energy contract. Their 15-year collaboration agreement has no definitive commercial terms yet.
- NANO's CEO James Walker and CFO Jaisun Garcha are consultants to LIS Technologies. Their FY2025 fees were $50,000 and $160,000.
- The CEO's brother, Jared Yu, received $120,000 through Udyr Tech and $250,000 through Financial Buzz Media Networks in FY2025, plus options.
18Legal cases · as of Nov 18, 2026
What legal cases does the LIS Technologies offer document list?
Cases are listed as the offer document describes them. A pending case is an allegation until a court or regulator decides it.
19What could go wrong
What could go wrong for LIS Technologies?
- Execution
No revenue and none expected soon
Revenue has been $0 since Dec 31, 2021, and net losses reached $65.4 million by Jul 31, 2026. The S-1/A (Nov 18, 2026) expects no revenue from uranium sales in the foreseeable future.
Watch Any signed fuel purchase agreement in a later filing.
- Technology
The technology is unproven at scale
An independent assessment in March 2025 placed CRISLA at level 4 of 9. The S-1/A warns that level may not reflect the true stage of development.
Watch A later assessment at level 5 or above, and results of the UF6 experiments.
- Regulation
A commercial plant needs an NRC license
The S-1/A (Nov 18, 2026) says a license is required before building or running a commercial plant, and that the review outcome is uncertain. The company says it is preparing its application. It estimates the NRC review could take about 18 months after it applies, and says there is no assurance on timing.
Watch The date the NRC application is filed.
- Cash and liquidity
It needs far more money than this offering
Management estimates about $74 million of cash needs for 12 months, and about $1.38 billion for the LEU-3 Facility. Money after costs is about $16.4 million at $6.00 (S-1/A, Nov 18, 2026).
Watch New share sales, debt or government awards in later filings.
- Competition
Established competitors
Centrus Energy and Urenco already run NRC-licensed U.S. plants. Orano and Global Laser Enrichment have applied for licenses. The S-1/A says many rivals have more resources.
Watch NRC decisions on the Orano and Global Laser Enrichment applications.
- Concentration
Reliance on NANO Nuclear
NANO Nuclear is a related party and its landlord, subcontractor and planned product partner. The S-1/A says no definitive commercial agreement exists.
Watch Definitive terms under the collaboration agreement.
- Governance
The CEO also runs NANO Nuclear
Mr. Yu is expected to give NANO no less than 40 hours a week, and about two hours a week to Human Continuum Inc. The S-1/A calls his LIS Technologies commitment a "lesser contractual standard".
Watch Changes to Mr. Yu's roles or agreements.
- Raw-material prices
Concentrated supply
The S-1/A says UF6 feedstock, fluorine, cylinders and equipment come from few suppliers. It says the company may have to buy some equipment, such as vacuum pumps, from abroad.
Watch Supply agreements for UF6 and equipment.
- Regulation
Export controls, an NNSA self-disclosure and government orders
The S-1/A says the technology faces export controls and possible classification. In September 2026 the company reported violations of certain Part 810 export rules to the Department of Energy's National Nuclear Security Administration (NNSA). It says these were primarily about document marking and the storage and transfer of export-controlled documents in its IT systems. The company says it has taken remedial actions and, as of the S-1/A's date (Nov 17, 2026), had not heard from the NNSA. It does not believe the matter is material to operating its business. The S-1/A also says the Department of Energy need not order beyond a minimum.
Watch New task orders under the $3.4 billion program.
20Risks of the offer
What risks does the LIS Technologies offer document flag?
Immediate dilution
At $6.00, the S-1/A's dilution section (Nov 18, 2026) shows net tangible book value of $0.68 a share after the offering, which is dilution of $5.32 a share for new buyers.
Many more shares could come
28,955,007 options and restricted stock units (Cityfort calculation from S-1/A filed Nov 18, 2026) sit outside the share count, against 3,100,000 shares offered. The S-1/A lists later sales after the lock-upA period after an IPO when insiders agree not to sell their shares. Learn more and staged releases as a risk.
Small number of shares to trade
New shares would be 4.14% of shares after the offering (Cityfort calculation from S-1/A filed Nov 18, 2026). The S-1/A says recent IPOs with comparable floats saw extreme volatility unrelated to business performance.
Broad discretion over the money
The S-1/A gives percentages of use, but says the company may change them and may acquire or license assets.
Insiders may buy in the offering
Mr. Yu and Mr. Liebenberg each indicated interest in buying up to $250,000 at the IPO price. Any shares affiliates buy would not be freely tradable, per the S-1/A.
Nevada law and company rules
The S-1/A lists Nevada anti-takeover law, an exclusive forum clause and a one-third meeting quorum. Officers and directors would hold 30.14% after the offering, counting options.
Less disclosure as an emerging growth company
The S-1/A gives two audited years instead of three, and the company may use other reduced reporting rules.
New owners and the NRC security clearance
The S-1/A says the company will need an NRC facility security clearance. The NRC grants one only if it determines the company is not under foreign ownership, control or influence to a degree inconsistent with the national interest. The S-1/A says ownership changes after the offering, including purchases by foreign persons, which the company may not be able to control, could affect its ability to obtain or maintain that clearance.
21How it got here
How did LIS Technologies get here?
2021
Milestone
Incorporated as SMR Nuclear Energy
Incorporated in British Columbia on Dec 31, 2021. It was renamed LIS Technologies in April 2023 and moved to Nevada in September 2023.
2023
Business-model change
Bought CRISLA Inc.
The purchase closed in August 2023. Former holders get shares at four milestones, a possible cash top-up, and a 5% royalty on future annual net sales.
2024
Milestone
NANO Nuclear collaboration and Department of Energy program
The 15-year NANO Nuclear collaboration runs from Nov 4, 2024, restated Sep 8, 2026. In December 2024 the two were selected for the department's program.
2025
Milestone
Level 4 assessment and Tennessee license
An independent assessment placed CRISLA at level 4 of 9 in March 2025. Tennessee issued a radiological material license in December 2025.
2026
Business-model change
Bought land and a building
It bought LIST Island, a 206-acre former industrial site, in January 2026, and 150 Americus Ave on Jul 27, 2026. It spent $24.9 million on property and equipment in the nine months to Jul 31, 2026.
2026
Milestone
UF6 delivered and security plan approved
A UF6 cylinder reached Oak Ridge in October 2026. The NRC approved its security procedures plan that month, active after a readiness review.
2026
Milestone
S-1 filed, then amended twice
After confidential drafts dated Jul 20 and Sep 10, 2026, it filed Form S-1 on Oct 26, 2026. It filed S-1/A amendments on Nov 5 and Nov 18, 2026, and investor presentations on Oct 30, Nov 6 and Nov 18.
Sources (3)
- LIS Technologies Inc. Amendment No. 2 to Form S-1 (S-1/A), filed Nov 18, 2026 (dated Nov 17, 2026; Registration No. 333-299634)
- LIS Technologies Inc. EDGAR filing list (submissions data), read Nov 19, 2026
- LIS Technologies Inc. free writing prospectus (investor presentation) dated Nov 18, 2026, superseding the Nov 6, 2026 FWP
22Supporters vs. critics
What do supporters and critics point to?
What supporters point to
- The Department of Energy selected LIS Technologies as one of six companies in a ten-year program, with $3.4 billion anticipated across all six (S-1/A, Nov 18, 2026).
- In October 2026 the NRC approved its security procedures plan for Oak Ridge, active after a readiness review, per the S-1/A.
- The balance sheet at Jul 31, 2026 shows no borrowings and $18.8 million of cash.
- It owns a 206-acre site and holds a Tennessee radiological material license issued in December 2025.
- Industry data from UxC, as cited in the S-1/A (Nov 18, 2026), project U.S. needs of about 11 million to 39 million SWU in 2045, against U.S. capacity under 5 million SWU a year.
What critics point to
- Revenue has been $0 since Dec 31, 2021, net losses reached $65.4 million by Jul 31, 2026, and there are no fuel purchase agreements.
- CRISLA was placed at level 4 of 9 in March 2025, and the S-1/A says no laser enrichment process is commercial.
- It was not among the three companies awarded $900 million each by the Department of Energy in January 2026.
- Management estimates about $74 million of cash needs for 12 months and about $1.38 billion for its planned plant, against about $16.4 million of money after costs at $6.00 (S-1/A, Nov 18, 2026).
- The CEO is expected to give NANO Nuclear no less than 40 hours a week, and NANO is also its landlord, a holder and a subcontractor.
23What changed · S-1/A (Amendments No. 1 and 2)
What changed on this page?
Updated Nov 19, 2026
- Moved the page to the S-1/A filed Nov 18, 2026, after an S-1/A filed Nov 5, 2026. The expected range is unchanged at $5.00 to $7.00.
- The company now sells 3,100,000 shares (was 2,833,334), and the underwriters' option is 465,000 shares (was 425,000).
- Money after costs at $6.00 is now about $16.4 million (was about $15.1 million); the expense allowance is 1.15% (was 0.5%), and dilution for new buyers is $5.32 a share (was $5.33).
- Shares after the offering are 74,811,408 (71,711,408 before, at Nov 13, 2026; was 74,444,742 after); at $6.00 the implied market value is $448.87 million (Cityfort calculation from S-1/A filed Nov 18, 2026; was $446.7 million).
- Northland Capital Markets is now named as co-manager beside Titan Partners, the sole bookrunner; Titan's warrant is now 217,000 shares (was 198,334). Officers and directors would hold 30.14% after the offering (was 30.19%), with ownership dated Nov 13, 2026.
- New risks: the company's September 2026 self-disclosure of export-rule violations to the NNSA, and foreign ownership and its NRC security clearance; the S-1/A adds Mr. Yu's role at Human Continuum Inc. and director Eric Forte's 60,000 shares.
24What to watch next
What should you watch next for LIS Technologies?
Next event
A further S-1/A or the final prospectus (424B4)
Date not announced yet.
Cash needs against cash on hand
The S-1/A filed Nov 18, 2026 estimates about $74 million of cash needs for the 12 months to Jul 31, 2027. It shows $18.8 million of cash at Jul 31, 2026 and about $16.4 million of money after costs at the $6.00 midpoint.
Final price and share count
A later filing would confirm or change the $5.00 to $7.00 range and the 3,100,000 shares stated in the S-1/A filed Nov 18, 2026.
Nasdaq approval
The company has applied, and the S-1/A says the offering will not complete without approval.
UF6 experiments
The company says in its S-1/A (Nov 18, 2026) that experiments are expected to begin before the end of 2026.
NRC application and technology level
The company says in its S-1/A (Nov 18, 2026) that it is preparing its NRC application and that its near-term goal is level 5.
Fuel purchase agreements
The S-1/A says there are none. It also says the NANO Nuclear agreement has no definitive commercial terms.
25Key facts
Key facts about LIS Technologies
- When is the LIS Technologies IPO date?
- Not yet stated in the S-1/A dated Nov 18, 2026.
- What is the LIS Technologies IPO price range?
- $5.00 to $7.00 per share, as stated in the S-1/A dated Nov 18, 2026.
- What ticker will LIS Technologies use?
- The S-1/A dated Nov 18, 2026 names the proposed ticker LIS on Nasdaq.
- What does LIS Technologies do?
- LIS Technologies Inc., of Oak Ridge, Tennessee, is developing a laser process called CRISLA to enrich uranium for nuclear reactors. Its S-1/A filed Nov 18, 2026 says it has not started commercial production or sales.
- How does LIS Technologies make money?
- LIS Technologies does not make money yet. Its revenue was $0 in FY2024, FY2025 and the nine months to Jul 31, 2026, per its S-1/A. Selling shares brought most of its $25.3 million of financing in those nine months.
- Is LIS Technologies profitable?
- No. LIS Technologies' net loss was $21.5 million in FY2025 (the year to Oct 31, 2025) and $29.7 million in the nine months to Jul 31, 2026, per its S-1/A.
- Who are LIS Technologies' customers?
- LIS Technologies has no customers buying fuel. Its S-1/A filed Nov 18, 2026 says it targets reactor operators and reactor developers, and has no offtake or future fuel purchase agreements. Its revenue was $0 in FY2025.
- What is CRISLA?
- CRISLA (Condensation Repression Isotope-Selective Laser Activation) is the laser enrichment process LIS Technologies owns. An independent assessment in March 2025 placed it at technology readiness level 4 of 9, per the S-1/A filed Nov 18, 2026.
- How big is LIS Technologies?
- LIS Technologies had 29 full-time employees at Sep 30, 2026, and $18.8 million of cash at Jul 31, 2026, per its S-1/A. Its revenue was $0 in the nine months to Jul 31, 2026.
- Who owns LIS Technologies before the IPO?
- CEO Jay Jiang Yu beneficially owned 25.92% of LIS Technologies at Nov 13, 2026, counting options, per its S-1/A. Officers and directors as a group owned 31.22% on the same basis.
- Who competes with LIS Technologies?
- LIS Technologies' S-1/A filed Nov 18, 2026 names Centrus Energy and Urenco, which run U.S. enrichment plants. It also names Orano, Global Laser Enrichment and General Matter, which have taken steps toward licenses.
- What is the LIS Technologies IPO?
- LIS Technologies plans to sell 3,100,000 new shares on the Nasdaq Capital Market under the proposed ticker LIS, per its S-1/A filed Nov 18, 2026. It states an expected range of $5.00 to $7.00, and the money goes to the company.
26Sources and changes
Where every number on this page comes from
Sources (3 documents)
- S8LIS Technologies Inc. EDGAR filing list (submissions data), read Nov 19, 2026 · SEC EDGAR · Tier 1: company or exchange filing · Nov 19, 2026
- S9LIS Technologies Inc. Amendment No. 2 to Form S-1 (S-1/A), filed Nov 18, 2026 (dated Nov 17, 2026; Registration No. 333-299634) · SEC EDGAR (filed by LIS Technologies Inc.) · Tier 1: company or exchange filing · Nov 18, 2026
- S10LIS Technologies Inc. free writing prospectus (investor presentation) dated Nov 18, 2026, superseding the Nov 6, 2026 FWP · SEC EDGAR (filed by LIS Technologies Inc.) · Tier 1: company or exchange filing · Nov 18, 2026
Changes to this page (v2 · Nov 19, 2026)
- v2 · Nov 19, 2026Moved the page to the S-1/A (Amendment No. 2) filed Nov 18, 2026 (S9), after the S-1/A of Nov 5, 2026 (S6, superseded); investor presentation of Nov 18 (S10, replacing S2 and S7); EDGAR list read Nov 19 (S8). From S6: 3,100,000 shares, 465,000-share option, 217,000-share warrant, Northland Capital Markets as co-manager. From S9: 1.15% expense allowance, about $16.4 million after costs, 71,711,408 shares at Nov 13 and 74,811,408 after, dilution $5.32, as-adjusted cash and equity, ownership at Nov 13, the NNSA self-disclosure, the security-clearance risk, NRC review timing, Mr. Yu's Human Continuum role, Mr. Forte's shares. Range unchanged. Unchanged figures cite S9; S1, S2, S5, S6 and S7 superseded. (updated for the S-1/A)
- v1 · Nov 5, 2026First version, based on the S-1 dated Oct 26, 2026. (first version, based on the S-1)
Numbers come only from tier 1 and tier 2 sources. Read how we research.
Disclaimer
For learning only. Cityfort is not a registered investment adviser or broker-dealer and does not recommend buying or selling any security. Prices shown are dated and may be out of date.
Investing in securities involves risk, including loss of capital. Before making any investment decision, do your own research and consider consulting a registered investment adviser or other qualified professional.
Cityfort, its owners and contributors may or may not hold securities of companies covered. Cityfort is not paid by any company it covers. Content is not an offer or solicitation to buy or sell any security, including in any initial public offering.
Read the positions policyRead the full disclaimerHide the full disclaimer
Cityfort publishes general educational content that explains how listed companies work. Cityfort is not registered with the US Securities and Exchange Commission or any state securities regulator as an investment adviser, and is not a broker-dealer or a member of FINRA. Cityfort does not provide investment, tax or legal advice, recommendations, ratings, price targets or any opinion on whether to buy, sell or hold any security. Nothing on the site is tailored to any person's circumstances.
All information is taken from publicly available sources, mainly company filings with the SEC, which are listed on each page with dates. We work to keep it accurate and correct errors publicly, but we do not guarantee that it is complete, accurate or up to date. Any market price or price-based ratio shown is dated, may be out of date by the time you read it, and is included only to explain concepts.
Statements by company management, including forward-looking statements and guidance, are reported as the company's statements, with their date and source; they are not our forecasts. Adjusted (non-GAAP) figures are the company's own measures and are shown next to the official (GAAP) figures.